Ambrosia Biosciences Inc., a drug-discovery company launched last year, has added Jason Haddock, a former executive with ArcherDX Inc. and Array BioPharma Inc., to its board of directors.

Martello Technologies Group Inc., ("Martello" or the "Company") (TSXV: MTLO), a provider of user experience management solutions for cloud communication and collaboration systems such as Microsoft ...

The MosaiQ AiPlex CD is designed to improve the  accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows EYSINS, Switzerland , Feb.

KT announced on the 9th that it will improve its telecommunications (CT) centered purchasing and partner management processes ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small ...

SeQure Dx specializes in assays that deliver precise editing confirmation and risk assessment for off-target effects, applicable across a wide range of viral and non-viral gene editing modalities.

FUJIFILM Corporation today announced that it will install new production facilities of CMP slurries*1, advanced ...

1992). To Dr Gloria Inés Sánchez (Group Infection and Cancer, Universidad de Antioquia) for help with manuscript critical reading and Carmen Beatriz Zuluaga for comments and suggestions. To the Group ...

Dxcover, a clinical-stage diagnostics company focused on detecting cancers, has received $6.2 million to drive innovation and expand its commercial presence. The investment round brings total funding ...

A growing library of quality lenses backs Nikon's mirrorless Z camera system. We're here to break down what's available and recommend the best optics we've tested. Images, and the devices that ...

3D22 3D2V Team will be active from Rotuma Island, IOTA OC - 060. Team - Members of the Rebel DX Group. Rotuma belongs to Fiji and is as far away from the heart of the archipelago as possible. The ...

Lynx Dx aims to address these challenges with the ... while maintaining 91–94% sensitivity for high-grade cancer (Grade Group ≥2). Patients now have the flexibility to complete the MPS2 ...